ORGANIGRAM GLOBAL INC (OGI) Stock Fundamental Analysis

NASDAQ:OGI • CA68617J1003

1.27 USD
-0.02 (-1.55%)
At close: Feb 17, 2026
1.31 USD
+0.04 (+3.15%)
After Hours: 2/17/2026, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Taking everything into account, OGI scores 4 out of 10 in our fundamental rating. OGI was compared to 191 industry peers in the Pharmaceuticals industry. OGI may be in some trouble as it scores bad on both profitability and health. OGI is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year OGI was profitable.
  • OGI had a negative operating cash flow in the past year.
  • OGI had negative earnings in each of the past 5 years.
  • OGI had negative operating cash flow in 4 of the past 5 years.
OGI Yearly Net Income VS EBIT VS OCF VS FCFOGI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50M -100M -150M -200M

1.2 Ratios

  • OGI's Return On Assets of 3.42% is amongst the best of the industry. OGI outperforms 83.25% of its industry peers.
  • Looking at the Return On Equity, with a value of 4.92%, OGI belongs to the top of the industry, outperforming 83.25% of the companies in the same industry.
Industry RankSector Rank
ROA 3.42%
ROE 4.92%
ROIC N/A
ROA(3y)-32.94%
ROA(5y)-24.98%
ROE(3y)-37.82%
ROE(5y)-28.71%
ROIC(3y)N/A
ROIC(5y)N/A
OGI Yearly ROA, ROE, ROICOGI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60 -80

1.3 Margins

  • OGI's Profit Margin of 6.49% is amongst the best of the industry. OGI outperforms 82.20% of its industry peers.
  • The Gross Margin of OGI (8.13%) is comparable to the rest of the industry.
Industry RankSector Rank
OM N/A
PM (TTM) 6.49%
GM 8.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OGI Yearly Profit, Operating, Gross MarginsOGI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • OGI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • OGI has more shares outstanding than it did 1 year ago.
  • OGI has more shares outstanding than it did 5 years ago.
  • OGI has a worse debt/assets ratio than last year.
OGI Yearly Shares OutstandingOGI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
OGI Yearly Total Debt VS Total AssetsOGI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • OGI has an Altman-Z score of -0.24. This is a bad value and indicates that OGI is not financially healthy and even has some risk of bankruptcy.
  • OGI has a Altman-Z score (-0.24) which is comparable to the rest of the industry.
  • OGI has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of OGI (0.17) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z -0.24
ROIC/WACCN/A
WACC8.44%
OGI Yearly LT Debt VS Equity VS FCFOGI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

2.3 Liquidity

  • A Current Ratio of 2.73 indicates that OGI has no problem at all paying its short term obligations.
  • The Current ratio of OGI (2.73) is comparable to the rest of the industry.
  • A Quick Ratio of 1.32 indicates that OGI should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.32, OGI is not doing good in the industry: 68.59% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.73
Quick Ratio 1.32
OGI Yearly Current Assets VS Current LiabilitesOGI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • OGI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 118.94%, which is quite impressive.
  • The Revenue has grown by 68.55% in the past year. This is a very strong growth!
  • Measured over the past years, OGI shows a very strong growth in Revenue. The Revenue has been growing by 24.46% on average per year.
EPS 1Y (TTM)118.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%169.31%
Revenue 1Y (TTM)68.55%
Revenue growth 3Y21.14%
Revenue growth 5Y24.46%
Sales Q2Q%48.7%

3.2 Future

  • The Earnings Per Share is expected to grow by 23.72% on average over the next years. This is a very strong growth
  • OGI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.68% yearly.
EPS Next Y106.12%
EPS Next 2Y53.54%
EPS Next 3Y37.96%
EPS Next 5Y23.72%
Revenue Next Year17.99%
Revenue Next 2Y12.89%
Revenue Next 3Y12.01%
Revenue Next 5Y9.68%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
OGI Yearly Revenue VS EstimatesOGI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M 400M
OGI Yearly EPS VS EstimatesOGI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -0.5 -1 -1.5 -2 -2.5

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 18.14, which indicates a rather expensive current valuation of OGI.
  • Compared to the rest of the industry, the Price/Earnings ratio of OGI indicates a rather cheap valuation: OGI is cheaper than 84.82% of the companies listed in the same industry.
  • OGI's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.16.
  • The Price/Forward Earnings ratio is 20.00, which indicates a rather expensive current valuation of OGI.
  • Based on the Price/Forward Earnings ratio, OGI is valued a bit cheaper than 77.49% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.10, OGI is valued a bit cheaper.
Industry RankSector Rank
PE 18.14
Fwd PE 20
OGI Price Earnings VS Forward Price EarningsOGI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OGI Per share dataOGI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as OGI's earnings are expected to grow with 37.96% in the coming years.
PEG (NY)0.17
PEG (5Y)N/A
EPS Next 2Y53.54%
EPS Next 3Y37.96%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • OGI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ORGANIGRAM GLOBAL INC

NASDAQ:OGI (2/17/2026, 8:00:02 PM)

After market: 1.31 +0.04 (+3.15%)

1.27

-0.02 (-1.55%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-10
Earnings (Next)05-11
Inst Owners7.7%
Inst Owner Change2.17%
Ins Owners0.24%
Ins Owner ChangeN/A
Market Cap170.60M
Revenue(TTM)279.99M
Net Income(TTM)18.17M
Analysts77.78
Price Target2.49 (96.06%)
Short Float %2.45%
Short Ratio1.84
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-513.86%
Min EPS beat(2)-2513.86%
Max EPS beat(2)1486.14%
EPS beat(4)2
Avg EPS beat(4)-68.73%
Min EPS beat(4)-2513.86%
Max EPS beat(4)1486.14%
EPS beat(8)3
Avg EPS beat(8)-105.21%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.72%
Min Revenue beat(2)-14%
Max Revenue beat(2)8.56%
Revenue beat(4)3
Avg Revenue beat(4)0.89%
Min Revenue beat(4)-14%
Max Revenue beat(4)8.56%
Revenue beat(8)5
Avg Revenue beat(8)-0.51%
Revenue beat(12)6
Avg Revenue beat(12)-2.26%
Revenue beat(16)8
Avg Revenue beat(16)-0.67%
PT rev (1m)-1.24%
PT rev (3m)15.08%
EPS NQ rev (1m)0%
EPS NQ rev (3m)62.96%
EPS NY rev (1m)29.48%
EPS NY rev (3m)878%
Revenue NQ rev (1m)-0.31%
Revenue NQ rev (3m)4.94%
Revenue NY rev (1m)0%
Revenue NY rev (3m)6.43%
Valuation
Industry RankSector Rank
PE 18.14
Fwd PE 20
P/S 0.83
P/FCF N/A
P/OCF N/A
P/B 0.63
P/tB 0.86
EV/EBITDA N/A
EPS(TTM)0.07
EY5.51%
EPS(NY)0.06
Fwd EY5%
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS1.53
BVpS2.02
TBVpS1.48
PEG (NY)0.17
PEG (5Y)N/A
Graham Number1.78
Profitability
Industry RankSector Rank
ROA 3.42%
ROE 4.92%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 6.49%
GM 8.13%
FCFM N/A
ROA(3y)-32.94%
ROA(5y)-24.98%
ROE(3y)-37.82%
ROE(5y)-28.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 89.52%
Cap/Sales 6.26%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.73
Quick Ratio 1.32
Altman-Z -0.24
F-Score4
WACC8.44%
ROIC/WACCN/A
Cap/Depr(3y)85.08%
Cap/Depr(5y)98.16%
Cap/Sales(3y)9.58%
Cap/Sales(5y)15.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)118.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%169.31%
EPS Next Y106.12%
EPS Next 2Y53.54%
EPS Next 3Y37.96%
EPS Next 5Y23.72%
Revenue 1Y (TTM)68.55%
Revenue growth 3Y21.14%
Revenue growth 5Y24.46%
Sales Q2Q%48.7%
Revenue Next Year17.99%
Revenue Next 2Y12.89%
Revenue Next 3Y12.01%
Revenue Next 5Y9.68%
EBIT growth 1Y24.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year260.96%
EBIT Next 3Y67.83%
EBIT Next 5Y40.89%
FCF growth 1Y36.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y43.8%
OCF growth 3YN/A
OCF growth 5YN/A

ORGANIGRAM GLOBAL INC / OGI FAQ

Can you provide the ChartMill fundamental rating for ORGANIGRAM GLOBAL INC?

ChartMill assigns a fundamental rating of 4 / 10 to OGI.


Can you provide the valuation status for ORGANIGRAM GLOBAL INC?

ChartMill assigns a valuation rating of 4 / 10 to ORGANIGRAM GLOBAL INC (OGI). This can be considered as Fairly Valued.


What is the profitability of OGI stock?

ORGANIGRAM GLOBAL INC (OGI) has a profitability rating of 3 / 10.


What is the valuation of ORGANIGRAM GLOBAL INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ORGANIGRAM GLOBAL INC (OGI) is 18.14 and the Price/Book (PB) ratio is 0.63.


Can you provide the expected EPS growth for OGI stock?

The Earnings per Share (EPS) of ORGANIGRAM GLOBAL INC (OGI) is expected to grow by 106.12% in the next year.